Magnetic resonance imaging (MRI) has been utilized as a promising approach both in clinical application and in experimental research. MRI demonstrates superior ability to investigate the anatomical, metabolic, perfusion, functional, and molecular characteristic of various tissues and organs without radiation injury or invasiveness; therefore, it has been performed in the detection, diagnosis, staging, grading, and treatment of various diseases.
Magnetic resonance imaging (MRI) has been utilized as a promising approach both in clinical application and in experimental research. MRI demonstrates superior ability to investigate the anatomical, metabolic, perfusion, functional, and molecular characteristic of various tissues and organs without radiation injury or invasiveness; therefore, it has been performed in the detection, diagnosis, staging, grading, and treatment of various diseases.
With extremely large population and ambition of national medical treatment enhancement, China has demonstrated excessive needs for advanced healthcare devices, including MRI scanner. Therefore, a rapid increase in the quantity of MRI scanner has been observed for the last decade, with the number raising from 2235 (1.77 per million people) in 2003 to 6400 (4.8 per million people) in 2013. In addition, there has been a massive concern and investment in the scientific research and the development of cutting-edge technology such as high-field (3.0T) MR and specific advanced applications such as functional MRI in China. From 2010 to 2013, the statistical data regarding to the national medical device summary has revealed a national increase rate >40% and 30% for 1.5T and 3.0T MRI scanners, respectively. High field MRI scanner, especially 3.0T, has provided a platform for more specific investigations on the properties of MRI in both clinical and scientific research in the future.
In the clinical practice, MRI has been confirmed as a significant approach in the qualitative and quantitative diagnosis as well as in monitoring the treatment effect of diseases in diverse organs, such as brain, spine, head and neck, breast, liver, kidney, prostate, cervix, bones and joints, and so on. Concerning the application of MRI, there are several significant previous findings in diverse fields. Gao et al. have reported that conventional MRI can reveal different retardations in subtle structures and development processes among different patterns of mild hypoxicischemic encephalopathy. Moreover, Le et al.'s study has demonstrated that high-resolution "bright blood" and "black blood" sequential MRI analysis is capable of the accurate analysis of the ingredients in atherosclerotic plaques and the evaluation of the severity of carotid arteriostenosis. In addition, in the latest version of international tumor, node, and metastasis (TNM) classification, the differentiation of clinical TNM stage for a range of cancers is on the basis of MRI findings instead of CT.
The focus of MRI application has been shifting from structural imaging to functional, metabolic, and molecular imaging perspectives, which benefits to improve the sensitivity, specificity and accuracy in the evaluation of the diagnosis, and to expand the performance of MRI in research. Quantitative MRI parameters to serve as imaging biomarkers, the objective measurement and evaluation of MRI as an indicator of normal biological processes, pathogenic processes or responses to the therapeutic intervention, have been suggested by multiple previous studies. These quantitative MRI techniques equip MRI with the underlying capability to be applied in the prognosis, diagnosis, staging of a disease, as well as the prediction and monitoring of the clinical response to a therapeutic intervention. Zhang et al. have suggested that diffusion weighted imaging (DWI) possesses the potential to be performed in distinguishing renal cell carcinomas (RCCs) from benign lesions in human small solid renal tumors, which demonstrates increasing accuracy for diagnosing RCCs while combined with nonenhanced MRI. Moreover, Wang et al. have confirmed that dynamic contrast enhancement (DCE)-MRI combined DWI can improve imaging performance in differentiating benign from malignant sinonasal tumors, which may improve the diagnostic accuracy and assist the oncologists with treatment arrangement. Quantitative MRI biomarkers can also assist with preclinical and clinical target identification, dosage instruction and schedule, and the revelation of the concept, mechanism, and drug efficacy. Commonly employed MRI biomarkers include parameters derived from DCE, DWI, spectroscopy, and arterial spin labeling (ASL). Additionally, quantitative chemical exchange saturation transfer (CEST) parameters have recently emerged as MRI biomarkers.
Magnetic resonance imaging has been applied in neuroscience research that focuses on neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) in clinical hospitals and research institutes in China. Major advances have occurred in the exploration of additional MRI biomarkers, including structural, perfusion, metabolic and anatomo-functional connectivity biomarkers for AD and PD for the past decade. The sophisticated techniques, such as tractography, three-dimensional ASL, CEST, spectroscopy, and resting state functional connectivity, demonstrate the potential applications in enhancing clinical diagnosis of AD and PD and monitoring the quality of clinical trials. Wang et al.'s study has suggested that amide proton transfer imaging can provide potential imaging biomarkers for the noninvasive molecular diagnosis of AD. Qin et al. have revealed the frequency dependence of the topological alterations of large-scale functional brain networks in AD. Additionally, Hu et al. have revealed the baseline and longitudinal changes of the fractional amplitude of low-frequency fluctuation values, which suggest that brain dysfunction induced with disease progression may affect the regions related to the corticostriato-pallido-thalamic loops and the cerebello-thalamocortical loops. Thus, the altered spontaneous neuronal activity of the cerebellum may be associated with disease progression in PD.
Nonalcoholic fatty liver diseases and hepatic fibrosis (HF) are observed to be popular in China, which is similar with that previously detected in the western countries. With combination of cutting-edge techniques such as iterative decomposition of water and fat with echo asymmetry and least-squares estimation-image quantification quantifying the fat content of liver, intravoxel incoherent motion-DWI and MR elastography (MRE), the diagnostic performance of MR approaches is enhanced to detect diffuse liver diseases and to serve as an alternative or complimentary role to invasive liver biopsy. Moreover, these cutting-edge techniques may as well improve the clinical diagnosis of chronic kidney diseases. Zou et al. have demonstrated that MRE parameters are more strongly correlated with the HF stages than that observed in DWI to provide more specific prediction on HF stages. Additionally, Wu et al. have reported that T2 signal intensity, apparent diffusion coefficient, and bi-exponential models parameters will vary during renal fibrotic processes, where bi-exponential model is superior to mono-exponential model in separating the modifications of micro-perfusion or tubular flow from pure diffusion.
In summary, with increasing applications of MRI in various perspectives, this approach has become a burgeoning and booming subspecialty in China. Chinese society of MRI in medicine was established in 2000, which has served as a platform for the communications among Chinese radiologists and related specialists, regarding to the purpose to improve understanding and application of the sophisticated MRI techniques.
Therefore, the requirement rises to summarize and to publish a national-wide MRI guideline including the selection of scanning sequences, the standardization of examination procedures, and the diagnostic guide in China. A prospective and multi-center study may be conducted to provide evidences for MRI guideline in clinical practice. Fortunately, a grand project aiming to establish a national MRI guideline has been approved by the Ministry of Health of China and is under execution. In addition, the optimal application of the newly emerged quantitative MRI parameters in clinical requires prior systemic evaluation including the matching of the modalities to the most appropriate physiologic parameters, the assessment of the ability to standardize modalities and algorithms across different platforms and among multiple institutions, and the validation of quantitative MRI parameters as the most appropriate imaging biomarkers against histological and immunohistochemical techniques.
